Skip to main content
Main navigation
Home
About pCPA
Who We Are
Governance
FAQs
Negotiations
Recent Updates
Forms and Publications
Brand Name Drugs
Negotiations Status
Negotiation Process
Generic Drugs
Biologics/Biosimilars
Contact Us
EN
FR
Dysport Therapeutic (abobotulinumtoxina)
pCPA File Number:
21045
Negotiation Status:
Concluded with an LOI
Indication(s):
Cervical dystonia
Sponsor/Manufacturer:
Ipsen Biopharmaceuticals
CADTH Project Number:
SR0512-000
pCPA Engagement Letter Issued:
2018-05-04
Negotiation Process Concluded:
2018-07-17